Altamira Therapeutics Ltd. Shortterm Employee Benefits Accruals
Altamira Therapeutics Ltd. (CYTOF) had Shortterm Employee Benefits Accruals of $209.03 thousand as of 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Notes
ifrs-full:ShorttermEmployeeBenefitsAccruals · last filed 2025-04-30
- 2023-12-31: Shortterm Employee Benefits Accruals 190.61K CHF.
- 2022-12-31: Shortterm Employee Benefits Accruals 362.50K CHF.
- 2021-12-31: Shortterm Employee Benefits Accruals 196.92K CHF.
- 2020-12-31: Shortterm Employee Benefits Accruals 101.82K CHF.
CHF
| Period end | Shortterm Employee Benefits Accruals |
|---|---|
| 2023-12-31 | 190.61K CHF 20-F/A · filed 2024-04-22 |
| 2022-12-31 | 362.50K CHF 20-F/A · filed 2024-04-22 |
| 2021-12-31 | 196.92K CHF 20-F · filed 2023-05-16 |
| 2020-12-31 | 101.82K CHF 20-F · filed 2022-04-12 |
| 2019-12-31 | 47.92K CHF 20-F · filed 2021-03-31 |
| 2018-12-31 | 146.95K CHF 20-F · filed 2020-04-16 |
| 2017-12-31 | 217.65K CHF 20-F · filed 2019-03-14 |
| 2016-12-31 | 138.96K CHF 20-F · filed 2018-03-22 |
USD
| Period end | Shortterm Employee Benefits Accruals |
|---|---|
| 2024-12-31 | $209.03K 20-F · filed 2025-04-30 |
| 2023-12-31 | $226.51K 20-F · filed 2025-04-30 |